Brevan Howard Capital Management’s Inhibikase Therapeutics IKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,384	Closed	-$22.7K	–	1823
2025 Q1	$22.7K	Buy	+10,384	New	+$22.7K	﹤0.01%	1068